Cyclacel Pharmaceuticals Reports Second Quarter Financial Results and Provides Business Update
Provided By GlobeNewswire
Last update: Aug 14, 2024
- Oral Fadraciclib Phase 2 Proof of Concept Study Enrolling Well -
- 065-101 PoC Interim Data Anticipated in the Fourth Quarter of 2024 -
- Management to Host Conference Call at 4:30 pm EDT Today -
3.71
-0.49 (-11.67%)
CYCLACEL PHARMACEUTICALS - CYCC 6 PERP
NASDAQ:CYCCP (7/11/2025, 8:02:39 PM)
After market: 4.12 -0.79 (-16.09%)4.91
-0.05 (-1.01%)
Find more stocks in the Stock Screener
CYCC Latest News and Analysis
11 days ago - ChartmillTop movers in Wednesday's sessionStay up-to-date with the latest market trends one hour before the close of the markets on Wednesday. Explore the top gainers and losers during today's session in our detailed report.
11 days ago - ChartmillThese stocks are moving in today's sessionCurious about what's happening in today's session? Check out the latest stock movements and price changes.
11 days ago - ChartmillGapping stocks in Wednesday's sessionLet's delve into the US markets on Wednesday and uncover the stocks that are experiencing notable gaps in today's session. Below, you'll find the gap up and gap down stocks.
